BDSX Biodesix

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients

LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced three Colorado-based events in October for healthcare professionals and community members to collaborate, learn, and advocate for lung health.

First Event: October 9th APAPP Know Your Nodules Event at Biodesix Head Office in Louisville, CO

The Association of Pulmonary Advanced Practice Providers (APAPP) Leadership and expert Faculty will run a half-day event: Know Your Nodules: Personalize. Prioritize. Prevent. APAPP Leadership will be hosting a clinician-centered lung disease and lung cancer screening / detection learning event at the Biodesix Corporate Headquarters in Louisville, Colorado. The event will also be live streamed. Faculty includes Corinne Young (President & Founder, APAPP), Stephen Deppen, PhD (Associate Professor of Thoracic Surgery and Epidemiology, Vanderbilt Medical Center), Rebecca Priebe (Acute Care Nurse Practitioner, Henry Ford Health), and Tammy Welch (Physician Assistant, Frederick Regional Health System).

Second Event: October 9th – 11th Go2 for Lung Cancer Centers of Excellence Summit in Denver, CO

The Go2 Association is hosting their annual Lung Cancer Centers of Excellence Summit in downtown Denver. This highly specialized educational event includes a full-day Lung Cancer Nurse Navigator module. Biodesix is a proud supporter of Go2 as they are driving to standardize best practices in lung nodule management at a national level. .

Third Event: October 12th American Lung Association in Colorado “Run the Rocks” at Red Rocks Amphitheater in Morrison, CO

The American Lung Association in Colorado holds their annual Run the Rocks fundraiser and community awareness event at the world-renowned Red Rocks Amphitheater. The purpose of this event is to raise funds for education, research, and advocacy to save lives by improving lung health and preventing lung disease. .

“It is a privilege and honor to collaborate with these three partners here in our home state of Colorado. They each uniquely assist in our journey to achieve the Biodesix mission to conquer lung diseases through personalized diagnostics,” said Scott Hutton, CEO at Biodesix. "I’d also like to note that these October events are well-timed as forerunners for November, which is Lung Cancer Awareness Month -- an important time of year for Biodesix advocacy and awareness efforts.”

About Biodesix:

Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.

Biodesix Contacts:

Media:

Natalie St. Denis, Director Corporate Communications, Biodesix



(720) 925-9285

Investors:

Chris Brinzey, Partner, ICR



(339) 970-2843



EN
06/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biodesix

 PRESS RELEASE

Biodesix Unveils October Lung Health Events in Colorado with the Assoc...

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced three Colorado-based events in October for healthcare professionals and community members to collaborate...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 23, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Biodesix Announces One-for-Twenty Reverse Stock Split

Biodesix Announces One-for-Twenty Reverse Stock Split LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Monday, September 15, 2025. The Company’s common stock will continue to trade under Biodesix’s existing trading symbol, BDSX, on the Nasdaq Global Market (“Nasdaq”) on a split-adjusted basis when the ...

 PRESS RELEASE

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Bes...

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025. Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference Date: Thursday, September 11, 2025Location: New York, NY1x1 meetings only About Biodesix ...

 PRESS RELEASE

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence...

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer LOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE) as part of Thermo Fisher’s collaborative initiative to advance NGS-based diagnostics. The services provided to Thermo Fisher are an example of Biodesix ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch